Page 146 - Read Online
P. 146

Sorrentino et al.                                                                                                                                                                               Role of A 2B  receptor in cancer

               metastasis development. Int J Biochem Cell Biol 2006;38:544-62.  in gastric cancer. Biochem Biophys Res Commun 2015;467:798-804.
           97.  Fang M, Xia J, Wu X, Kong H, Wang H, Xie W, Xu Y. Adenosine   113. Long JS, Schoonen PM, Graczyk D, O’Prey J, Ryan KM.
               signaling inhibits CIITA-mediated  MHC class II transactivation  in   p73  engages  A2B  receptor  signalling  to  prime  cancer  cells  to
               lung fibroblast cells. Eur J Immunol 2013;43:2162-73.  chemotherapy-induced death. Oncogene 2015;34:5152-62.
           98.  Xia J, Fang M, Wu X, Yang Y, Yu L, Xu H, Kong H, Tan Q, Wang H,   114. Hajiahmadi S, Panjehpour M,  Aghaei M, Shabani M.  Activation
               Xie W, Xu Y. A2b adenosine signaling represses CIITA transcription   of  A2b adenosine receptor regulates ovarian cancer cell growth:
               via an epigenetic mechanism in vascular smooth muscle cells.   involvement of Bax/Bcl-2 and caspase-3.  Biochem Cell Biol
               Biochim Biophys Acta 2015;1849:665-76.            2015;93:321-9.
           99.  Ben Addi A, Lefort A, Hua X, Libert F, Communi D, Ledent C,   115. Daniele S, Zappelli E, Natali L, Martini C,  Trincavelli ML.
               Macours P,  Tilley SL, Boeynaems JM, Robaye B. Modulation of   Modulation of  A1 and  A2B adenosine receptor activity: a new
               murine dendritic cell function by adenine nucleotides and adenosine:   strategy to sensitise glioblastoma stem cells to chemotherapy. Cell
               involvement of the A(2B) receptor. Eur J Immunol 2008;38:1610-20.  Death Dis 2014;5:e1539.
           100. Wilson  JM,  Ross  WG,  Agbai  ON,  Frazier  R,  Figler  RA,  Rieger   116.  Desmet CJ, Gallenne T, Prieur A, Reyal F, Visser NL, Wittner BS,
               J, Linden J, Ernst PB.  The  A2B adenosine receptor impairs the   Smit MA, Geiger TR, Laoukili J, Iskit S, Rodenko B, Zwart W, Evers
               maturation and immunogenicity of dendritic cells.  J Immunol   B, Horlings H, Ajouaou A, Zevenhoven J, van Vliet M, Ramaswamy
               2009;182:4616-23.                                 S,  Wessels  LF,  Peeper  DS.  Identification  of  a  pharmacologically
           101. Xaus J, Valledor AF, Cardó M, Marquès L, Beleta J, Palacios JM,   tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.
               Celada A. Adenosine inhibits macrophage colony-stimulating factor-  Proc Natl Acad Sci U S A 2013;110:5139-44.
               dependent proliferation of macrophages through the induction of   117. Przybylski M. A review of the current research on the role of bFGF
               p27kip-1 expression. J Immunol 1999;163:4140-9.   and VEGF in angiogenesis. J Wound Care 2009;18:516-9.
           102. Ryzhov S, Novitskiy SV, Goldstein  AE, Biktasova  A, Blackburn   118.  Feoktistov I, Goldstein AE, Ryzhov S, Zeng D, Belardinelli L, Voyno-
               MR, Biaggioni I, Dikov MM, Feoktistov I. Adenosinergic regulation   Yasenetskaya  T, Biaggioni  I. Differential  expression of adenosine
               of the expansion and immunosuppressive activity of CD11b+Gr1+   receptors  in human endothelial  cells: role  of  A2B receptors  in
               cells. J Immunol 2011;187:6120-9.                 angiogenic factor regulation. Circ Res 2002;90:531-8.
           103. Gabrilovich DI, Ostrand-Rosenberg S, Bronte  V. Coordinated   119.  Feoktistov I, Ryzhov S, Zhong H, Goldstein AE, Matafonov A, Zeng
               regulation of myeloid cells by tumours.  Nat Rev Immunol   D, Biaggioni I. Hypoxia modulates  adenosine  receptors  in human
               2012;12:253-68.                                   endothelial  and smooth muscle cells toward an  A2B angiogenic
           104. Cekic C, Sag D, Li  Y,  Theodorescu D, Strieter RM, Linden J.   phenotype. Hypertension 2004;44:649-54.
               Adenosine  A2B receptor blockade slows growth of bladder and
               breast tumors. J Immunol 2012;188:198-205.     120. Merighi S, Simioni C, Gessi S, Varani K, Mirandola P, Tabrizi MA,
           105. Iannone R, Miele L, Maiolino P, Pinto A, Morello S. Blockade of A2b   Baraldi PG, Borea PA. A(2B) and A(3) adenosine receptors modulate
               adenosine receptor reduces tumor growth and immune  suppression   vascular endothelial growth factor and interleukin-8 expression
               mediated by myeloid-derived suppressor cells in a mouse model of   in human melanoma cells treated with etoposide and doxorubicin.
               melanoma. Neoplasia 2013;15:1400-9.               Neoplasia 2009;11:1064-73.
           106. Morello S, Miele L.  Targeting the adenosine A2b receptor in the   121. Zeng D, Maa T, Wang U, Feoktistov I, Biaggioni I, Belardinelli L.
               tumor microenvironment overcomes local immunosuppression by   Expression and function of A 2B adenosine receptors in the U87MG
               myeloid-derived suppressor cells. Oncoimmunology 2014;3:e27989.  tumor cells. Drug Develop Res 2003;58:405-11.
           107. Wei Q, Costanzi S, Balasubramanian R, Gao ZG, Jacobson KA. A2B   122. Sorrentino C, Miele L, Porta A, Pinto A, Morello S. Myeloid-derived
               adenosine receptor blockade inhibits growth of prostate cancer cells.   suppressor cells contribute to  A2B adenosine receptor-induced
               Purinergic Signal 2013;9:271-80.                  VEGF production and angiogenesis in a mouse melanoma model.
           108. Vecchio EA, Tan CY, Gregory KJ, Christopoulos A, White PJ, May   Oncotarget 2015;6:27478-89.
               LT. Ligand-independent adenosine A2B receptor constitutive activity   123. Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid
               as a promoter of prostate cancer cell proliferation. J Pharmacol Exp   cells  in  the  promotion  of  tumour  angiogenesis.  Nat  Rev  Cancer
               Ther 2016;357:36-44.                              2008;8:618-31.
           109. Kasama H, Sakamoto  Y, Kasamatsu  A, Okamoto  A, Koyama  T,   124. Allard  B,  Turcotte  M, Spring K, Pommey  S, Royal  I, Stagg J.
               Minakawa Y, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.   Anti-CD73 therapy impairs tumor angiogenesis.  Int J Cancer
               Adenosine A2b receptor promotes progression of human oral cancer.   2014;134:1466-73.
               BMC Cancer 2015;15:563.                        125. Sorrentino C, Miele L, Porta A, Pinto A, Morello S. Activation of
           110.  Gessi S, Merighi S, Varani K, Cattabriga E, Benini A, Mirandola P,   the  A2B adenosine  receptor  in  B16 melanomas  induces  CXCL12
               Leung  E,  Mac  Lennan  S, Feo C, Baraldi  S, Borea  PA. Adenosine   expression  in  FAP-positive  tumor  stromal  cells,  enhancing  tumor
               receptors in colon carcinoma  tissues and colon tumoral  cell  lines:   progression. Oncotarget 2016;7:64274-88.
               focus on the A(3) adenosine subtype. J Cell Physiol 2007;211:826-36.  126. Orimo  A, Gupta PB, Sgroi DC,  Arenzana-Seisdedos F, Delaunay
           111.  Ma  DF,  Kondo  T,  Nakazawa  T,  Niu  DF,  Mochizuki  K, Kawasaki   T, Naeem  R, Carey  VJ, Richardson  AL,  Weinberg RA. Stromal
               T, Yamane T, Katoh R. Hypoxia-inducible adenosine A2B receptor   fibroblasts  present  in  invasive  human  breast  carcinomas  promote
               modulates  proliferation  of colon carcinoma  cells.  Hum Pathol   tumor growth and angiogenesis through elevated  SDF-1/CXCL12
               2010;41:1550-7.                                   secretion. Cell 2005;121:335-48.
           112.  Wang P, Guo X, Zong W, Song B, Liu G, He S. MicroRNA-128b   127. Öhlund D, Elyada E,  Tuveson D. Fibroblast heterogeneity in the
               suppresses tumor growth and promotes apoptosis by targeting A2bR   cancer wound. J Exp Med 2014;211:1503-23.







            138                                                                       Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ July 17, 2017
   141   142   143   144   145   146   147   148   149   150   151